Capricor Therapeutics Statistics
Total Valuation
CAPR has a market cap or net worth of $526.74 million. The enterprise value is $379.85 million.
| Market Cap | 526.74M |
| Enterprise Value | 379.85M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CAPR has 58.14 million shares outstanding. The number of shares has increased by 24.20% in one year.
| Current Share Class | 58.14M |
| Shares Outstanding | 58.14M |
| Shares Change (YoY) | +24.20% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 0.93% |
| Owned by Institutions (%) | 57.86% |
| Float | 42.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 9.31 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.35, with a Debt / Equity ratio of 0.37.
| Current Ratio | 7.35 |
| Quick Ratio | 7.22 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.38 |
Financial Efficiency
Return on equity (ROE) is -73.70% and return on invested capital (ROIC) is -38.11%.
| Return on Equity (ROE) | -73.70% |
| Return on Assets (ROA) | -33.63% |
| Return on Invested Capital (ROIC) | -38.11% |
| Return on Capital Employed (ROCE) | -40.25% |
| Weighted Average Cost of Capital (WACC) | 7.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$560,245 |
| Employee Count | 231 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CAPR has paid $1,600 in taxes.
| Income Tax | 1,600 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.01% in the last 52 weeks. The beta is 0.72, so CAPR's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +49.01% |
| 50-Day Moving Average | 10.28 |
| 200-Day Moving Average | 23.52 |
| Relative Strength Index (RSI) | 49.13 |
| Average Volume (20 Days) | 6,156,500 |
Short Selling Information
The latest short interest is 22.18 million, so 38.16% of the outstanding shares have been sold short.
| Short Interest | 22.18M |
| Short Previous Month | 17.75M |
| Short % of Shares Out | 38.16% |
| Short % of Float | 52.07% |
| Short Ratio (days to cover) | 2.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | -99.73M |
| Operating Income | -135.16M |
| Pretax Income | -129.41M |
| Net Income | -129.42M |
| EBITDA | -133.07M |
| EBIT | -135.16M |
| Earnings Per Share (EPS) | -$2.47 |
Balance Sheet
The company has $237.93 million in cash and $91.05 million in debt, with a net cash position of $146.89 million or $2.53 per share.
| Cash & Cash Equivalents | 237.93M |
| Total Debt | 91.05M |
| Net Cash | 146.89M |
| Net Cash Per Share | $2.53 |
| Equity (Book Value) | 246.22M |
| Book Value Per Share | 4.24 |
| Working Capital | 209.17M |
Cash Flow
In the last 12 months, operating cash flow was -$104.00 million and capital expenditures -$25.78 million, giving a free cash flow of -$129.78 million.
| Operating Cash Flow | -104.00M |
| Capital Expenditures | -25.78M |
| Depreciation & Amortization | 2.09M |
| Net Borrowing | n/a |
| Free Cash Flow | -129.78M |
| FCF Per Share | -$2.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CAPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -24.20% |
| Shareholder Yield | -24.20% |
| Earnings Yield | -24.57% |
| FCF Yield | -24.64% |
Analyst Forecast
The average price target for CAPR is $27.00, which is 198.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $27.00 |
| Price Target Difference | 198.01% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 5, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 5, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |